Amexdrug (AXRX) Stock Statistics & Valuation Metrics

Amexdrug has a market cap or net worth of $33.88K. The enterprise value is $41.22M.

Amexdrug has 169,410,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Amexdrug’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.85%.

The current PE Ratio of Amexdrug is 1580.0. Amexdrug’s PEG ratio is 4.87.

In the last 12 months, Amexdrug had revenue of 10.43M and earned 111.36K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Amexdrug pays an annual dividend of ―, resulting in a dividend yield of ―

Amexdrug upcoming earnings date is ―, ―.

Amexdrug as a current ratio of 1.50, with Debt / Equity ratio of ―

In the past 12 months, Amexdrug has paid 56.77K in taxes.

Amexdrug EV to EBITDA ratio is 181.75, with an EV/FCF ratio of 1.50K.

Amexdrug has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 2.06%, and net profit margin of 1.07%.

The average price target for Amexdrug is ―, which is 11.43% higher than the current price. The consensus rating is ―